Trevi Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | 02/17/2026 | 13.22 M | $165.54 M | 0.00% | 9.11% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 10.26 M | $128.45 M | 0.00% | 7.07% |
| BLACKROCK, INC. | 02/12/2026 | 10.13 M | $126.78 M | 2.27% | 6.98% |
| FMR LLC | 02/17/2026 | 6.50 M | $81.38 M | 96.98% | 4.48% |
| VANGUARD GROUP INC | 01/29/2026 | 6.43 M | $80.56 M | 10.43% | 4.43% |
| VIVO CAPITAL, LLC | 02/13/2026 | 5.09 M | $63.79 M | 0.00% | 3.51% |
| MARSHALL WACE, LLP | 02/13/2026 | 4.58 M | $57.35 M | -5.39% | 3.16% |
| RUBRIC CAPITAL MANAGEMENT LP | 02/13/2026 | 3.77 M | $47.16 M | -55.85% | 2.60% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 3.40 M | $42.62 M | 4.61% | 2.35% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 3.29 M | $41.15 M | -3.52% | 2.27% |
| VIKING GLOBAL INVESTORS LP | 02/17/2026 | 3.20 M | $40.05 M | -37.63% | 2.20% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 3.19 M | $39.95 M | -3.56% | 2.20% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 3.08 M | $38.60 M | -28.18% | 2.12% |
| OCTAGON CAPITAL ADVISORS LP | 02/17/2026 | 2.82 M | $35.24 M | 0.00% | 1.94% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 2.62 M | $32.83 M | 89.84% | 1.81% |
| STATE STREET CORP | 02/13/2026 | 2.44 M | $30.49 M | 9.71% | 1.68% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.41 M | $30.21 M | 8.64% | 1.66% |
| SIREN, L.L.C. | 02/13/2026 | 2.29 M | $28.63 M | -9.85% | 1.58% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 2.15 M | $26.92 M | -23.21% | 1.48% |
| ACORN CAPITAL ADVISORS, LLC | 02/17/2026 | 2.14 M | $26.85 M | 0.00% | 1.48% |
| ARTIA GLOBAL PARTNERS LP | 02/17/2026 | 2.01 M | $25.21 M | 0.70% | 1.39% |
| EMERALD ADVISERS, LLC | 02/09/2026 | 1.89 M | $23.69 M | 100.00% | 1.30% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 1.77 M | $22.12 M | 25.22% | 1.22% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 1.55 M | $19.41 M | -29.55% | 1.07% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.53 M | $19.18 M | 13,507.01% | 1.06% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 02/09/2026 | 1.27 M | $15.93 M | 100.00% | 0.88% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 02/13/2026 | 1.26 M | $15.73 M | 0.00% | 0.87% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 02/17/2026 | 1.11 M | $13.88 M | 100.00% | 0.76% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.09 M | $13.71 M | -40.39% | 0.75% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.06 M | $13.23 M | 34.22% | 0.73% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 02/09/2026 | 1.05 M | $13.19 M | 0.51% | 0.73% |
| MORGAN STANLEY | 02/13/2026 | 1.05 M | $13.15 M | -75.58% | 0.72% |
| WOODLINE PARTNERS LP | 02/17/2026 | 1.00 M | $12.52 M | 897.47% | 0.69% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 1.00 M | $12.52 M | 6.17% | 0.69% |
| NAN FUNG TRINITY (HK) LTD | 02/04/2026 | 917.45 K | $11.49 M | 924.23% | 0.63% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 900.00 K | $11.27 M | 3,500.00% | 0.62% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 836.80 K | $10.48 M | 3.78% | 0.58% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 825.55 K | $10.34 M | -48.43% | 0.57% |
| NORTHERN TRUST CORP | 02/17/2026 | 761.97 K | $9.54 M | 3.40% | 0.53% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2026 | 693.00 K | $8.68 M | 21.48% | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 598.53 K | $7.49 M | -7.05% | 0.41% |
| BARCLAYS PLC | 02/13/2026 | 582.65 K | $7.29 M | 168.65% | 0.40% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 570.23 K | $7.14 M | -21.63% | 0.39% |
| PRUDENTIAL FINANCIAL INC | 02/13/2026 | 549.22 K | $6.88 M | -8.87% | 0.38% |
| EAM INVESTORS, LLC | 02/12/2026 | 541.24 K | $6.78 M | -1.50% | 0.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 541.24 K | $6.78 M | -8.08% | 0.37% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 02/17/2026 | 525.00 K | $6.57 M | 0.00% | 0.36% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 01/28/2026 | 507.69 K | $6.36 M | -18.18% | 0.35% |
| INVESCO LTD. | 02/19/2026 | 498.93 K | $6.25 M | 3.28% | 0.34% |
| J. GOLDMAN & CO LP | 02/17/2026 | 444.36 K | $5.56 M | -43.95% | 0.31% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Trevi Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 214 institutional investors and hedge funds held shares of Trevi Therapeutics Inc. The most heavily invested institutionals were:
EMERALD ADVISERS, LLC: 1.84 M
Pictet Asset Management Holding SA: 1.71 M
EMERALD MUTUAL FUND ADVISERS TRUST: 1.26 M
NAN FUNG TRINITY (HK) Ltd: 1.14 M
FLPUTNAM INVESTMENT MANAGEMENT CO: 1.06 M
Candriam S.C.A.: 773,620
89.80% of Trevi Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 145.00 M shares in the last 24 months. This purchase volume represents approximately $1.70 B in transactions.